Monitoring Agency Report for the Quarter ended June 30, 2025
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bajaj Healthcare has filed its Monitoring Agency Report for Q1 FY26 (quarter ended June 30, 2025) with the stock exchanges. Monitoring Agency Reports are mandatory quarterly submissions by companies that have raised funds through public issues such as IPOs, FPOs, or rights issues, and are required to track whether the proceeds are being used in line with the objectives disclosed at the time of fundraising. The report essentially certifies the status of fund utilisation and any deviations, if any, from the stated purpose. The actual content of the report — including deployment status, pending utilisation amount, and any qualifications by the monitoring agency — is not available from the headline alone. Investors should review the full report on the NSE/BSE website to assess whether the company is on track with its stated use of proceeds.
This is generally a routine compliance filing and is unlikely to move the stock price on its own, unless the report flags material deviations, unutilised funds, or concerns from the monitoring agency about how the money is being deployed.